title: The safety of chronic antithrombotic therapy in patients with factor XI deficiency.
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, New York, NY, USA.
authors.forename: John
authors.initials: J
authors.lastname: Chapin
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, New York, NY, USA.
authors.forename: Kelsey
authors.initials: K
authors.lastname: Klute
authors.affiliation: Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY, USA.
authors.forename: Paul
authors.initials: P
authors.lastname: Christos
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, New York, NY, USA.
authors.forename: Maria
authors.initials: M
authors.lastname: DeSancho
mesh_terms: D005173:Factor XI Deficiency / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents
keywords: anticoagulation; bleeding disorders; factor XI